Extraparenchymal neurocysticercosis: Report of five cases and review of management

Juan C. Bandres, A. Clinton White, Tobias Samo, Edward C. Murphy, Richard L. Harris

Research output: Contribution to journalArticle

85 Scopus citations

Abstract

Neurocysticercosis due to parenchymal cysts carries a good prognosis regardless of therapy. Extraparenchymal neurocysticercosis (including ventricular, spinal, and subarachnoid types) carries a poorer prognosis. Most extraparenchymal cases present with hydrocephalus. Medical treatment alone in doses and schedules developed for parenchymal disease is frequently unsuccessful. For ventricular disease, most cases can be managed with shunting procedures either alone or together with the administration of antiparasitic agents (e.g., praziquantel or albendazole), without extirpation of the cysts. Subarachnoid disease was formerly associated with a case fatality rate of about 50%. However, with the combination of shunting procedures for hydroceph-alus, antiparasitic agents, and, in some cases, surgical extirpation of the cysts, the prognosis is much improved. Spinal cysticercosis can be either leptomeningeal (which responds like subarachnoid disease) or intramedullary. For all forms of neurocysticercosis, the role of antiparasitic agents needs to be better defined.

Original languageEnglish (US)
Pages (from-to)799-811
Number of pages13
JournalClinical Infectious Diseases
Volume15
Issue number5
StatePublished - Nov 1992
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Immunology

Cite this

Bandres, J. C., White, A. C., Samo, T., Murphy, E. C., & Harris, R. L. (1992). Extraparenchymal neurocysticercosis: Report of five cases and review of management. Clinical Infectious Diseases, 15(5), 799-811.